PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Hypogonadism • Understanding Hypergonadism • Pathophysiology • Symptoms • Diagnosis • Treatment PART 06: Pipeline analysis • TESTAVAN • Vibex QST • LPCN 1021 • REXTORO • Enclomiphene • LPCN 1111 • TSX-002 • TEFINA • THG-1001 • MetP Testosterone Nasal Gel PART 07: Key buying criteria PART 08: Market landscape • Global endocrinology drugs market • Global testosterone replacement therapy market • Five forces analysis PART 09: Market segmentation by dosage form • Gels • Injectables • Patches • Others PART 10: Geographical segmentation • Global testosterone replacement therapy market by geography 2015-2020 • Testosterone replacement therapy market in Americas • Testosterone replacement therapy market in EMEA • Testosterone replacement therapy market in APAC PART 11: Market drivers • Increase in older population • High incidence of testosterone deficiency • Rise in chronic diseases • Increase in awareness PART 12: Impact of drivers PART 13: Market challenges • Generic erosion • FDA warnings on use of testosterone products • Adverse effects • Physicians are reluctant to prescribe medications with testosterone • Reluctance to discuss condition PART 14: Impact of drivers and challenges PART 15: Market trends • Entry of SARMs • Support of patient assistance programs • Focus on emerging markets • Application in new therapeutic indications PART 16: Vendor landscape • Competitive scenario • Market analysis 2015 • AbbVie • Allergan • Eli Lilly • Endo International • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Normal levels of testosterone based on gender Exhibit 03: Normal levels of testosterone at different ages Exhibit 04: Timeline of testosterone replacement therapy products Exhibit 05: Advantages and risks associated with use of testosterone products Exhibit 06: Causes of hypogonadism Exhibit 07: Symptoms of hypogonadism Exhibit 08: Diagnostic algorithm of hypogonadism Exhibit 09: Pipeline portfolio: Global testosterone drugs market Exhibit 10: Key buying criteria for testosterone replacement therapy Exhibit 11: Global endocrinology drugs market 2015-2020 ($ billions) Exhibit 12: Market share of global testosterone replacement therapy market in global endocrinology drugs market Exhibit 13: Global testosterone replacement therapy market 2015-2020 ($ billions) Exhibit 14: Five forces analysis Exhibit 15: Global testosterone replacement therapy market by dosage form 2015 Exhibit 16: Segmentation of global testosterone replacement therapy market based on geography 2015 Exhibit 17: Global testosterone replacement therapy market by geography 2015-2020 ($ billions) Exhibit 18: Global testosterone replacement therapy market by geography 2015-2020 Exhibit 19: Testosterone replacement therapy market in Americas 2015-2020 ($ billions) Exhibit 20: Percentage share of US in testosterone replacement therapy market 2015 Exhibit 21: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions) Exhibit 22: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions) Exhibit 23: Global testosterone replacement therapy market: YoY growth and revenue based on geography 2015-2020 Exhibit 24: Impact of drivers Exhibit 25: Impact of drivers and challenges Exhibit 26: AbbVie: YoY revenue and growth rate of AndroGel 2013-2015 ($ billions) Exhibit 27: AbbVie: Key takeaways Exhibit 28: Allergan: Key takeaways Exhibit 29: Eli Lilly: YoY revenue and growth rate of Axiron 2013-2015 ($ millions) Exhibit 30: Geographical segmentation of Axiron by revenue 2015 Exhibit 31: Eli Lilly: Key takeaways Exhibit 32: Endo International: YoY revenue and growth rate of Fortesta 2013-2015 ($ millions) Exhibit 33: Endo: Key takeaways

AbbVie, Allergan, Eli Lilly, Endo International, Acerus Pharmaceuticals, Antares Pharma, Bayer HealthCare Pharmaceuticals, Bedford Labs, Clarus Therapeutics, Ferring Pharmaceuticals, Forendo Pharma, Juniper Pharmaceuticals, Lipocine, MetP Pharma, Mylan, Pfizer, ProStrakan, Repros Therapeutics, Sandoz, TesoRx, Teva Pharmaceuticals.